Movement Alert|Corning Falls 4.77% in Regular Trading, JPMorgan Places Stock on Negative Catalyst Watch Citing Excessive Valuation

Market Focus07-17 21:31

On July 17, Corning fell 4.77% in regular trading, trading at $151.39/share with turnover of $75.45 million, extending the prior session's over 9% decline and bringing the cumulative pullback from its late-June all-time high to approximately 38%.

On the news front, JPMorgan placed Corning on its Negative Catalyst Watch list ahead of the company's Q2 earnings release scheduled for July 28. The bank emphasized that the concern is not deteriorating fundamentals but rather an excessively elevated valuation. Analysts noted that Corning's forward P/E based on 2028 estimates exceeds 30x, implying roughly 40x for its optical communications segment, leaving virtually no room for error heading into the report. JPMorgan maintained its Neutral rating and $200 price target. Market consensus expects adjusted EPS of $0.75 and revenue of $4.63 billion for Q2. Despite the recent correction, Corning's year-to-date gain remains near 100%, with profit-taking pressure intensifying as the earnings date approaches.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment